BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
Public ClinicalTrials.gov record NCT01290406. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Single-arm Study of Orally Administered BEZ235 as Second-line Therapy in Patients With Advanced or Metastatic Endometrial Carcinoma
Study identification
- NCT ID
- NCT01290406
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- BEZ235 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2012
- Primary completion
- Aug 31, 2014
- Completion
- Nov 30, 2017
- Last update posted
- Jun 20, 2012
2012 – 2017
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital & Medical Center | Phoenix | Arizona | 85013 | — |
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | — |
| City of Hope Medical center | Duarte | California | 91010 | — |
| Holy Cross Hospital | Silver Spring | Maryland | 20910-1484 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Morriswon Memorial Hospital | Morristown | New Jersey | 07960 | — |
| Carolinas Healthcare Systems | Charlotte | North Carolina | 28203 | — |
| Cancer Centers of North Carolina | Raleigh | North Carolina | 27607 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73126-0901 | — |
| GHS | Danville | Pennsylvania | — | — |
| Sarah Gautam Rau | Nashville | Tennessee | 37203-1197 | — |
| Texas Oncology, P.A. | Austin | Texas | — | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| STOH | San Antonio | Texas | — | — |
| Pacific Gynecology Specialists | Seattle | Washington | 98104 | — |
| Cancer Care Northwest | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01290406, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 20, 2012 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01290406 live on ClinicalTrials.gov.